206 related articles for article (PubMed ID: 35756659)
1. Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer.
Wang K; Mei S; Cai M; Zhai D; Zhang D; Yu J; Ni Z; Yu C
Front Oncol; 2022; 12():888699. PubMed ID: 35756659
[TBL] [Abstract][Full Text] [Related]
2. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
3. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
Peng J; Hao Y; Rao B; Zhang Z
Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas.
Mao K; Tang R; Wu Y; Zhang Z; Gao Y; Huang H
Front Genet; 2023; 14():1118273. PubMed ID: 36923797
[TBL] [Abstract][Full Text] [Related]
5. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
6. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
Front Oncol; 2021; 11():738477. PubMed ID: 34568075
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis.
Dai Z; Zhong Y
Transl Cancer Res; 2022 Jun; 11(6):1665-1677. PubMed ID: 35836516
[TBL] [Abstract][Full Text] [Related]
9. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
10. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
11. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
Front Genet; 2022; 13():760514. PubMed ID: 35273635
[No Abstract] [Full Text] [Related]
12. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
[No Abstract] [Full Text] [Related]
13. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
14. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
15. A Novel Prognostic Ferroptosis-Related lncRNA Signature Associated with Immune Landscape in Invasive Breast Cancer.
Shen S; Yang D; Yang Y; Chen Y; Xiong J; Hu X
Dis Markers; 2022; 2022():9168556. PubMed ID: 35359880
[TBL] [Abstract][Full Text] [Related]
16. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer.
Xiao S; Liu X; Yuan L; Wang F
Front Cell Dev Biol; 2021; 9():736682. PubMed ID: 34926441
[No Abstract] [Full Text] [Related]
17. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
19. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
Pan J; Zhang X; Fang X; Xin Z
Front Genet; 2021; 12():739470. PubMed ID: 34497636
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
